UPC
Universe Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.76M
P/E Ratio
—
EPS
$-8.06
Beta
1.48
52W High
$11.00
52W Low
$2.00
50-Day MA
$2.97
200-Day MA
$3.84
Dividend Yield
—
Profit Margin
-20.60%
Forward P/E
—
PEG Ratio
—
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, a pharmaceutical company, is engaged in the manufacture, marketing, distribution and sale of products derived from traditional Chinese medicine in China.
Fundamentals
| Revenue (TTM) | $17.86M |
| Gross Profit (TTM) | $6.30M |
| EBITDA | $-2.40M |
| Operating Margin | -6.77% |
| Return on Equity | -7.23% |
| Return on Assets | -2.66% |
| Revenue/Share (TTM) | $39.17 |
| Book Value | $99.64 |
| Price-to-Book | 0.03 |
| Price-to-Sales (TTM) | 0.10 |
| EV/Revenue | 0.0174 |
| EV/EBITDA | 0.31 |
| Quarterly Earnings Growth (YoY) | -82.00% |
| Quarterly Revenue Growth (YoY) | -14.10% |
| Shares Outstanding | 563,340 |
| Float | 559,870 |
| % Insiders | 0.62% |
| % Institutions | 5.19% |
Historical Volatility
HV 10-Day
110.50%
HV 20-Day
101.72%
HV 30-Day
92.60%
HV 60-Day
93.98%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/14/2026